EAM

Exome Asset Management Portfolio holdings

AUM $202M
1-Year Est. Return 151.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+151.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$148M
AUM Growth
+$35.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$4.65M
2
+$4.41M
3
+$4.12M
4
GILD icon
Gilead Sciences
GILD
+$3.82M
5
SWTX
SpringWorks Therapeutics
SWTX
+$3.76M

Top Sells

1
+$5.2M
2
+$3.84M
3
+$3.64M
4
ONC
BeOne Medicines Ltd
ONC
+$3.22M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.03M

Sector Composition

1 Healthcare 98.79%
2 Financials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$664K 0.45%
353,434
52
$642K 0.43%
298,575
+139,400
53
$583K 0.39%
262,625
+111,749
54
$462K 0.31%
468,499
-659,200
55
$377K 0.26%
137,174
56
$280K 0.19%
126,901
57
$264K 0.18%
+102,631
58
$128K 0.09%
75,300
59
– –
-18,000
60
– –
-82,400
61
– –
-86,700
62
– –
-43,865
63
– –
-514,900
64
– –
-162,100
65
– –
-839,472
66
– –
-209,092
67
– –
-57,800
68
– –
-300,200
69
– –
-84,790
70
– –
-25,928
71
– –
-369,322
72
– –
-302,700
73
– –
-271,400
74
– –
-19,800
75
– –
-10,800
1 2
3
4